Bruker (NASDAQ: BRKR) director awarded 4,520 RSUs vesting in 2027

Rhea-AI Filing Summary

BRUKER CORP director William A. Linton received an equity award of 4,520 restricted stock units (RSUs). The RSUs were granted at no cash cost and relate to the company’s common stock. After this grant, he directly holds 63,243 shares of common stock.

The footnote explains that these RSUs will vest in a single installment on February 15, 2027, and each RSU will automatically convert into one share of Bruker common stock at that time, aligning the director’s compensation more closely with future shareholder value.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider LINTON WILLIAM A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,520	$0.00	--

Holdings After Transaction: Common Stock — 63,243 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LINTON WILLIAM A

(Last) (First) (Middle)

PROMEGA

2800 WOODS HOLLOW ROAD

(Street)

MADISON WI 53711-5399

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BRUKER CORP [ BRKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/15/2026		A		4,520(1)	A	$0	63,243	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.

	/s/ Michael Simone, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Bruker (BRKR) director William A. Linton report on this Form 4?

Bruker director William A. Linton reported receiving an equity grant of 4,520 restricted stock units. These units relate to Bruker common stock and increase his direct equity-based compensation, aligning his interests with long-term shareholder value through future share conversion.

How many Bruker (BRKR) shares does William A. Linton own after this RSU grant?

After the reported transaction, William A. Linton directly owns 63,243 shares of Bruker common stock. This figure reflects his holdings following the award of 4,520 restricted stock units, as disclosed in the Form 4 filing for the non-derivative transaction.

What are the key terms of William A. Linton’s RSU grant at Bruker (BRKR)?

The RSU grant consists of 4,520 restricted stock units that vest in one installment on February 15, 2027. On that vesting date, each RSU will automatically convert into a corresponding share of Bruker common stock, subject to the grant’s standard conditions.

Does William A. Linton pay a purchase price for the Bruker (BRKR) RSU grant?

No cash purchase price is reported for this RSU grant, with the transaction price per share shown as 0.0000. This indicates the award represents stock-based compensation rather than an open-market purchase of Bruker common shares by the director.

When will William A. Linton’s Bruker (BRKR) RSUs convert into common stock?

The restricted stock units are scheduled to vest in a single installment on February 15, 2027. On that vesting date, each RSU will automatically convert into an equivalent number of Bruker common shares, according to the terms described in the Form 4 footnote.

Is this Bruker (BRKR) Form 4 transaction a purchase or a compensation award?

The transaction is classified as a grant, award, or other acquisition under code A, not an open-market purchase. It represents stock-based compensation through 4,520 restricted stock units rather than a traditional buy transaction at a stated market price per share.